8:12 AM ET
8-K
Reverse Stock Split
Jasper Therapeutics Reverse Stock Split
Jasper Therapeutics announced a 1-for-30 reverse stock split of its common stock, effective November 6, 2026. The split will reduce the number of outstanding shares from approximately 33.3 million to 1.1 million to increase the per-share trading price on the Nasdaq Capital Market. The authorized number of shares remains unchanged at 490 million, resulting in an increase in authorized but unissued shares available for future use.